TB Notes Newsletter
No. 2, 2014
Dr. Mase Provides Expert Commentary for Medscape on MDR TB and Bedaquiline
Medscape from WebMD provides medical news features, commentary, and reference content for physicians, nurses, pharmacists, and other health professionals. CDC and Medscape collaborate to produce a special series of CDC expert commentaries designed to deliver guidance directly to Medscape's physicians and other health-care professionals. In this series, experts from CDC offer video commentaries on current topics.
In March 2014, DTBE participated in the CDC Expert Commentary Series. Dr. Sundari Mase, Medical Team Lead in the Field Services and Evaluation Branch, DTBE, recorded the commentary, New Drug Available to Treat Multidrug-Resistant Tuberculosis, at CDC’s broadcast studios in Atlanta. This commentary details the recently released CDC guidelines for the use and monitoring of the new TB drug bedaquiline. The commentary was posted on March 31, 2014, on Medscape’s website where it can be viewed after a short registration process. As an alternative, it can be viewed on the DTBE website on the Drug-Resistant TB webpage.
Other examples of Medscape’s CDC Expert Commentary Series, including the 2011 commentary recorded by former DTBE Director Dr. Kenneth Castro titled, What’s New in Blood Testing for TB Infection?, and the 2012 commentary he recorded titled, New Regimen Makes Treating Latent Tuberculosis Infection Easier. Both of these are available on Medscape’s “CDC Expert Commentary” webpage.
—Reported by Nicole Richerdson-Smith, MA
Div of TB Elimination